Rivastigmine Impurity 6 | CAS 1369779-38-3 - Request Quote
Rivastigmine Impurity 6
| SZ CAT No: | SZ-R018025 |
| CAS No | 1369779-38-3 |
| Mol.F. | C10H15NO2 |
| Mol.Wt. | 181.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivastigmine Impurity 6 is chemically (S)-3-(1-Dimethylaminoethyl) phenol N-oxide. Rivastigmine Impurity 6 is supplied with detailed characterization data compliant with regulatory guideline. Rivastigmine Impurity 6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivastigmine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1369779-38-3
Purchase 1369779-38-3
Order 1369779-38-3
Enquire 1369779-38-3
price of 1369779-38-3
1369779-38-3 Supplier
1369779-38-3 Manufacturer
1369779-38-3 Exporter
buy high quality Rivastigmine Impurity 6
Purchase Rivastigmine Impurity 6
Rivastigmine Impurity 6 suppliers
Rivastigmine Impurity 6 manufacturers
Rivastigmine Impurity 6 price
Order Rivastigmine Impurity 6
Enquire Rivastigmine Impurity 6
Rivastigmine Impurity 6 cost
Rivastigmine Impurity 6 Supplier
Rivastigmine Impurity 6 Distributor
Rivastigmine Impurity 6 for Method Validation
Rivastigmine Reference Standard
Rivastigmine Impurity 6 for ANDA Filing
Rivastigmine Impurity 6 for Forced Degradation Studies
Rivastigmine Impurity 6 Identification Standards
Rivastigmine Impurity 6 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


